Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2000-03-30
2002-07-16
Kemmerer, Elizabeth (Department: 1646)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023100, C435S320100, C435S325000, C435S252300, C435S007100, C530S350000, C530S351000, C530S387100, C530S387900
Reexamination Certificate
active
06420543
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates generally to growth factors and specifically to a new member of the transforming growth factor beta (TGF-&bgr;) superfamily, which is denoted, growth differentiation factor-15 (GDF-15).
2. Description of Related Art
The transforming growth factor &bgr; (TGF-&bgr;) superfamily encompasses a group of structurally-related proteins which affect a wide range of differentiation processes during embryonic development. The family includes, Mullerian inhibiting substance (MIS), which is required for normal male sex development (Behringer, et al.,
Nature,
345:167, 1990), Drosophila decapentaplegic (DPP) gene product, which is required for dorsal-ventral axis formation and morphogenesis of the imaginal disks (Padgett, et al.,
Nature,
325:81-84, 1987), the Xenopus Vg-1 gene product, which localizes to the vegetal pole of eggs (Weeks, et al.,
Cell,
51:861-867, 1987), the activins (Mason, et al.,
Biochem, Biophys. Res. Commun.,
135:957-964, 1986), which can induce the formation of mesoderm and anterior structures in Xenopus embryos (Thomsen, et al.,
Cell
63:485, 1990), GDNF, which can promote the survival of motor neurons and midbrain dopaminergic neurons (Lin, et al.,
Science
260:1130, 1993; Tomae, et al.,
Nature
373:335, 1995; Beck, et al.,
Nature
373:339, 1995; Henderson, et al.,
Science
266:1062, 1994; Van, et al.,
Nature
373:341, 1995; Oppenheim, et al.,
Nature
373:344, 1995) and the bone morphogenetic proteins (BMPs, osteogenin, OP-1) which can induce de novo cartilage and bone formation (Sampath, et al.,
J. Biol. Chem.,
265:13198, 1990). The TGF-&bgr;s can influence a variety of differentiation processes, including adipogenesis, myogenesis, chondrogenesis, hematopoiesis, and epithelial cell differentiation (for review, see Massague,
Cell
49:437, 1987).
The proteins of the TGF-&bgr; family are initially synthesized as a large precursor protein which subsequently undergoes proteolytic cleavage at a cluster of basic residues approximately 110-140 amino acids from the C-terminus. The C-terminal regions, or mature regions, of the proteins are all structurally related and the different family members can be classified into distinct subgroups based on the extent of their homology. Although the homologies within particular subgroups range from 70% to 90% amino acid sequence identity, the homologies between subgroups are significantly lower, generally ranging from only 20% to 50%. In each case, the active species appears to be a disulfide-linked dimer of C-terminal fragments. Studies have shown that when the pro-region of a member of the TGF-&bgr; family is coexpressed with a mature region of another member of the TGF-&bgr; family, intracellular dimerization and secretion of biologically active homodimers occur (Gray, A., and Maston, A.,
Science
247:1328, 1990). Additional studies by Hammonds, et al., (
Molec. Endocrin.
5:149, 1991) showed that the use of the BMP-2 pro-region combined with the BMP-4 mature region led to dramatically improved expression of mature BMP-4. For most of the family members that have been studied, the homodimeric species has been found to be biologically active, but for other family members, like the inhibins (Ling, et al.,
Nature
321:779, 1986) and the TGF-&bgr;s (Cheifetz, et al.,
Cell
48:409, 1987), heterodimers have also been detected, and these appear to have different biological properties than the respective homodimers.
Identification of new factors that are tissue-specific in their expression pattern will provide a greater understanding of that tissue's development and function.
SUMMARY OF THE INVENTION
The present invention provides a cell growth and differentiation factor, GDF-15, a polynucleotide sequence which encodes the factor, and antibodies which are bind to the factor. This factor appears to relate to various cell proliferative disorders.
Thus, in one embodiment, the invention provides a method for detecting a cell proliferative disorder which is associated with GDF-15. In another embodiment, the invention provides a method for treating a cell proliferative or immunologic disorder by suppressing or enhancing GDF-15 activity.
In another embodiment, the invention provides a method for identifying GDF-15 receptor polypeptide comprising incubating components comprising GDF-15 polypeptide and a cell expressing a receptor or a soluble receptor under conditions sufficient to allow the GDF to bind to the receptor; measuring the binding of the GDF polypeptide to the receptor; and isolating the receptor. Methods of isolating the receptors are described in more detail in the Examples section.
REFERENCES:
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5350836 (1994-09-01), Kopchick et al.
M. Bootcov, et al.; MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-&bgr; superfamily; Proc. Natl. Acad. Sci. USA, Oct. 1997, pp. 11514-11519.
R. Hromas, et al.; PLAB, a novel placental bone morphogenetic protein; Biochimica et Biophysica Acta , 1354; 1997; pp. 40-44.
Vishwas M. Paralkar, et al.; Cloning and Characterization of a Novel Member of the Transforming Growth Factor-&bgr;/Bone Morphogenetic Protein Family; The Journal of Biological Chemistry, vol. 273, No. 22, Issue of May 29, 1998; pp. 13760-13767.
N.Q. McDonald, et al.; A structural superfamily of growth factors containing a cysteine knot motif; Cell, May 7, 1993; vol. 73, pp. 421-424, see entire document.
R.M. Lyons, et al.; Transforming growth factors and the regulation of cell proliferation; European Journal of Biochemistry; 1990, vol. 187, pp. 467-473, see entire document.
M.B. Sporn, et al.; Transforming growth factor-beta: new chemical forms and new biological roles. BioFactors, 1988, vol. 1, No. 1, pp. 89-93, see entire document.
J. Massague; The TGF-&agr; family of growth and differentiation factors; Cell; May 22, 1987; vol. 49, pp. 437-438, see entire document.
Benjamin et al., 1998, Development 125:1591-1598.*
Vukicevic et al., 1996, PNAS USA 93:9021-9026.*
Massague, 1987, Cell 49:437-438.*
Pilbeam et al., 1993, Bone 14:717-720.*
Skolnick et al., 2000, Trends in Biotech. 18:34-39.*
Bork, 2000, Genome Research 10:398-400.*
Doerks et al., 1998, Trends in Genetics 14:248-250.*
Smith et al., 1997, Nature Biotechnology 15:1222-1223.*
Brenner, 1999, Trends in Genetics 15:132-133.*
Bork et al., 1996, Trends in genetics 12:425-426.*
Bottner et al., 1999, Gene 237:105-111.*
Hsiao et al., 2000, Mol. Cell. Biol. 20:3742-3751.*
Wells, 1990, Biochemistry 29:8609-8517.*
Ngo et al., 1994, The Protein Foldiong Problem and Tertiary Structure Prediction, Merz et al., eds., Birkhauser, Boston, pp. 492-495.
Hsiao Edward
Huynh Thanh
Lee Se-Jin
Rankin Christopher
Sebald Suzanne
Gray Cary Ware & Friedenrich LLP
Haile Lisa A.
Kemmerer Elizabeth
The Johns Hopkins University School of Medicine
LandOfFree
Growth differentiation factor-15 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Growth differentiation factor-15, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Growth differentiation factor-15 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2843155